Another ViewEPS of 24c matched estimates; revenue of $213.6M missed estimates of $222.6M. EBITDA of $41.7M matched estimates. Revenue rose 1.7%, EPS rose from 19c last year. North America was strong; Europe was weak. Revenue guidance was raised, to $1B, from estimates of $957M. EBITDA margin is forecast at 20%. Debt ratios fell. Very strong EPS growth (88c to $1.21) is the consensus for next year. We are comfortable with the results. Savaria has however been very strong leading into these, so we are not sure there will be a dramatic reaction. We would still consider it buyable. (5iResearch)